Shares Magazine
0.63p+0.00 (+0.00%)05 Dec 2025, 08:56
Jump to:
Provexis PLC Fundamentals
| Company Name | Provexis PLC | Last Updated | 2025-12-05 |
|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
| Shares in Issue | 2.346 bn | Market Cap | £14.66 m |
| PE Ratio | 0.39 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | £-0.00 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.3250 | Cash Equity Ratio | 0.9270 |
| Quick Ratio | 3.1840 | Current Ratio | 4.08 |
| Price To Book Value | 11.2994 | ROCE | 0 |
Provexis PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Provexis PLC Company Financials
| Assets | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 |
| Stocks | £202,352.00 | £136,520.00 | £327,797.00 | £85,808.00 |
| Debtors | £82,202.00 | £125,479.00 | £61,114.00 | £104,443.00 |
| Cash & Equivalents | £708,087.00 | £189,357.00 | £379,121.00 | £863,873.00 |
| Other Assets | 0 | 0 | 0 | 0 |
| Total Assets | £1.01 m | £498,036.00 | £845,992.00 | £1.13 m |
| Liabilities | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Creditors within 1 year | £248,206.00 | £307,448.00 | £188,337.00 | £157,909.00 |
| Creditors after 1 year | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | £248,206.00 | £307,448.00 | £188,337.00 | £157,909.00 |
| Net assets | £763,815.00 | £190,588.00 | £657,655.00 | £969,080.00 |
| Equity | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Called up share capital | £2.35 m | £2.22 m | £2.22 m | £2.21 m |
| Share Premium | £19.43 m | £18.70 m | £18.70 m | £18.68 m |
| Profit / Loss | -£449,637.00 | -£601,998.00 | -£419,916.00 | -£299,132.00 |
| Other Equity | £1.30 m | £724,337.00 | £1.19 m | £1.50 m |
| Preference & Minorities | -£533,749.00 | -£533,749.00 | -£531,874.00 | -£529,999.00 |
| Total Capital Employed | £763,815.00 | £190,588.00 | £657,655.00 | £969,080.00 |
| Ratios | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 | 0 |
| Assets / Equity | 1.3250 | 1.3250 | 1.3250 | 1.3250 |
| Cash / Equity | 0.9270 | 0.9270 | 0.9270 | 0.9270 |
| EPS | £-0.00 | £-0.00 | £-0.00 | £-0.00 |
| Cash Flow | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash from operating activities | -£340,829.00 | -£191,498.00 | -£520,739.00 | -£213,615.00 |
| Cashflow before financing | £516,801.00 | -£191,498.00 | -£485,639.00 | -£213,615.00 |
| Increase in Cash | £518,730.00 | -£189,764.00 | -£484,752.00 | -£213,537.00 |
| Income | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Turnover | £1.29 m | £801,964.00 | £389,916.00 | £426,168.00 |
| Cost of sales | £759,304.00 | £518,169.00 | £95,497.00 | £46,119.00 |
| Gross Profit | £532,940.00 | £283,795.00 | £294,419.00 | £380,049.00 |
| Operating Profit | -£451,971.00 | -£603,592.00 | -£420,927.00 | -£299,205.00 |
| Pre-Tax profit | -£449,637.00 | -£601,998.00 | -£419,916.00 | -£299,132.00 |
Provexis PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats. |
| Latest Interim Date | 31 Dec 2025 |
| Latest Fiscal Year End Date | 30 Oct 2025 |
Provexis PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2008-09-01 | Mr. Krijn Rietveld | Non-Executive Director |
| 2011-12-01 | Mr. Steven Neil Morrison | Executive Director,Chief Operating Officer |
| 2011-08-09 | Dr. Neville Clifford Bain | Non-Executive Director,Deputy Chairman |
| 2014-08-29 | Mr. Stephen Nigel Moon | Executive Director,Chief Executive Officer |
| 2025-10-29 | Mr. Charles Dawson Buck | Non-Executive Director,Chairman |
| 2025-10-29 | Mr. Ian Ford | Executive Director,Chief Executive Officer and Company Secretary |
| 2011-08-09 | Mr. Stewart William Slade BSc,ACA | Executive Director,Finance Director and Company Secretary |
| 2025-10-29 | Dr. Niamh Ann O'Kennedy | Executive Director,Chief Scientific Officer |
Provexis PLC Contact Details
| Company Name | Provexis PLC |
|---|---|
| Address | Prospect House, 58 Queens Road, Reading, RG1 4RP |
| Telephone | +44 7917670260 |
| Website | https://www.provexis.com |
Provexis PLC Advisors
| Solicitor | TLT LLP |
|---|
| Registrar | Equiniti Ltd. |
|---|---|
| Phone | +44 1214157082 |
| Stockbroker | Cenkos Securities |
|---|---|
| Phone | +44 2073978900 |
| Fax | +44 2073978901 |
| Financial PR Adviser | Haggie Partners LLP |
|---|---|
| Phone | +44 2075624444 |
| Nominated Adviser | Cenkos Securities |
|---|---|
| Phone | +44 2073978900 |
| Fax | +44 2073978901 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Trustpilot Group PLC | 146.40 | 13.31 |
| Greggs PLC | 1,674.00 | 5.28 |
| Ssp Group PLC | 172.30 | 4.49 |
| Elementis PLC | 166.80 | 4.12 |
| Rightmove PLC | 540.20 | 3.33 |
| Pinewood Technologies Group PLC | 370.00 | 2.92 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Baltic Classifieds Group PLC | 175.40 | -5.70 |
| Mony Group PLC | 181.80 | -5.31 |
| Trainline PLC | 209.00 | -4.91 |
| Big Yellow Group PLC | 1,024.00 | -4.30 |
| Oxford Nanopore Technologies PLC | 124.70 | -4.30 |
| Goodwin PLC | 19,650.00 | -3.68 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.